Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicity
Melica Nourmoussavi Brodeur(Memorial Sloan Kettering Cancer Center), Dmitriy Zamarin(Tisch Hospital)
Cited by 9
Related Papers
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|408
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
|Journal of Clinical Investigation|2018|148